SPATA31F2P
Putative protein SPATA31F2P
Also known as: S31F2_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- Q63HN1
- Gene
- SPATA31F2P
- Canonical length
- 556 aa
OverviewNCBI Gene
No narrative summary is available for SPATA31F2P in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
556 residues, UniProt reviewed canonical sequence.
>Q63HN1|SPATA31F2P
1 MHPMALHMVL PAHLPFLSPE VLRLLEVHVK KWMHFQRWGL PRRVEESLRQ LMPNPPLYYQ
61 PGNDQPVSFN LNNTSQVSLH RSETISLQTW CSCVAGQPIQ TFWVSEWSTM NPEQRHHCQQ
121 TPNPMALALP SPALKALSGP HPQSGGQDND SGSDLQQKYS QLFCGLPSLH SESLVATFMG
181 SQGLPKIENV PKPPLKDPFL FNDLSFPQLL PKTSPQSAPP SSPLSPNWVS PSDHQRAQIN
241 VPFLTLAEYE ALEWHLLQRQ LQLQWGWPAA LQRSQHTQCL MQHEPCGKAQ SPETTTASQT
301 GKSISVLTRE LLFFPEHARK LLEFHIQKQS IRHRWGLPQK IQQSIQLLLT STDQQTVSSS
361 STALANVSIP QPVALEANGA CDVLSPIAAP VSIPRPHLLT QVKAILQSHI DSKCGQIHQG
421 KIPACVHRSW DCRISGVLAV APFPCIPESQ FLVLQTASDP DLHHKVMPWM PTALDQQQQA
481 LPGTVTEHPK LLRVLSVEAI EKLETTLRHK HLAFLSGLPA LYYVALPRAL APAVTSQSVI
541 TEMEPSPVEI PAEPLILocalizationUniProt · AlphaFold · HPA
Whether an antibody against SPATA31F2P can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.65
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Protein domainsUniProt · Pfam · InterPro
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SPATA31F2P as an antibody target. Whether an autoantibody or antibody against SPATA31F2P could matter depends on whether native SPATA31F2P is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SPATA31F2P is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SPATA31F2P as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...